http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18772107

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 8
issn 2090-2190
2090-2182
pageRange 701814-8
publicationName Molecular Biology International
startingPage 701814
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7b06054cb3290cb2ff62e3b094b84de7
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7582fd250b241ffd612704eae54b9727
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1c473aad8bd785a3d8d127e31a5809ee
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d41992466720eb7dde4f45340af5001d
bibliographicCitation Meng W, Huebner A, Shabsigh A, Chakravarti A, Lautenschlaeger T. Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer. Molecular Biology International. 2012 Mar 11;2012():1–8. doi: 10.1155/2012/701814.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfff567860659c649541337966d197b7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e46226e37e2508b54d06b555fd0121b1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d2e6a6c970dc9b92b68e1d1d15ad8e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41010297df77534bb09c1219c18d4faf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ce96f11b9ac119e52d91d3976108fae
date 2012-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/22530128
https://pubmed.ncbi.nlm.nih.gov/PMC3316979
https://doi.org/10.1155/2012/701814
isPartOf https://portal.issn.org/resource/ISSN/2090-2182
https://portal.issn.org/resource/ISSN/2090-2190
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39552
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_77f827d4e87d70655efe46686f0c91c2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68245
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ce339711a92d17db84b2c2bd4bd633cd
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10199
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cc85f1a1e5552bbfd36778d6070784f6
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7172
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7173

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127676247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129308074
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID166824

Total number of triples: 45.